Roles of DNA-PK and FACT in Cancer Cell Response to Cisplatin
Author Information
Author(s): Sand-Dejmek Janna, Adelmant Guillaume, Sobhian Bijan, Calkins Anne S, Marto Jarrod, Iglehart Dirk J, Lazaro Jean-Bernard
Primary Institution: Dana-Farber Cancer Institute
Hypothesis
The study aims to elucidate the mechanism underlying the effects of DNA-PK on cisplatin sensitivity.
Conclusion
Both DNA-PK and FACT play roles in DNA repair, but their inhibition may lead to different therapeutic effects in cancer treatment.
Supporting Evidence
- Silencing DNA-PKcs increased sensitivity to cisplatin and decreased γH2AX appearance.
- FACT and DNA-PK co-localize at sites of DNA damage.
- Depletion of SSRP1 increased both apoptosis and necrosis in cisplatin-treated cells.
Takeaway
This study looks at how two proteins, DNA-PK and FACT, help cancer cells survive after being treated with a drug called cisplatin, and how blocking these proteins can change how the cells respond.
Methodology
The study involved silencing DNA-PKcs and SSRP1 in cancer cell lines and assessing their sensitivity to cisplatin through various assays.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website